Abstract
Acyber-physical system (CPS) establishes a close interaction between system’s computational core and the control of physical process. In case of Diabetes, failure in endogenous insulin production requires exogenous infusion of required drug amount. We have proposed an architecture for artificial pancreas and checked its validity in simulations. The aim is to control blood glucose level (BGL) of a patient suffering from diabetes and to prevent the harmful state of Hypoglycemia. For this, vital signs monitoring is introduced through which hypoglycemic condition can be efficiently detected and avoided. Electrocardiogram, Heart beat rate, Electroencephalography and skin resistance are known to depict an irregularity in blood glucose. Upon detection, a specified amount of Glucagon is infused into patient’s body. The system consists of an insulin infusion and glucagon pump, through which insulin/glucagon is entered into the patient’s body subcutaneously, based on the current BGL. A neural network predictive controller is designed to keep the glucose level inside the desired ’safe range’. The simulations have shown that patient safety can be improved through this strategy.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lee, I., Sokolsky, O.: Medical Cyber Physical Systems. In: Proc. of DAC, Anaheim, California, USA (2010)
High Confidence Software and Systems Coordinating Group. High-confidence medical devices: Cyber-physical systems for 21st century health care. A Research and Development Needs Report, NCO/NITRD (February 2009)
Bergman, R.N., Phillips, L.S., Cobelli, C.: Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β -cell glucose sensitivity from the response to intravenous glucose. Journal of Clinical Investigation 68(6), 1456–1467 (1981)
Dua, P., Doyle, F.J., Pistikopoulos: Model-Based Blood Glucose Control for Type 1 Diabetes via Parametric Programming. IEEE Transactions on Biomedical Engineering 53, 1478–1491 (2006)
Diabetes Control and Complications Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977–986 (1993)
Banting, F.G., Best, C.H., Collip, J.B., Campbell, W.R., Fletcher, A.A.: Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. Cmaj 145(10), 1281–1286 (1922) (reprinted 1991)
Cryer, P.E.: Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 45(7), 937–948 (2002)
Hovorka, R., Chassin, L.J., Wilinska, M.E., Canonico, V., Akwi, J.A., Federici, M.O., Massi- Benedetti, M., Hutzli, I., Zaugg, C., Kaufmann, H., Both, M., Vering, T., Schaller, H.C., Schaupp, L., Bodenlenz, M., Pieber, T.R.: Closing the loop: the adicol experience. Diabetes Technol. Ther. 6(3), 307–318 (2004)
Farmer Jr., T.G., Edgar, T.F., Peppas, N.A.: The future of open- and closed-loop insulin delivery systems. J. Pharm. Pharmacol. 60(1), 1–13 (2008)
El Youssef, J., Castle, J., Kenneth Ward, W.: A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes. Algorithms 2, 518–532 (2009)
Weinzimer, S.A., Steil, G.M., Swan, K.L., Dziura, J., Kurtz, N., Tamborlane, W.V.: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 31(5), 934–939 (2008)
Elbein, S.C., Wegner, K., Kahn, S.E.: Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds. Diabetes Care 23(2), 221–227 (2000)
Bellazzi, R., Nucci, G., Cobelli, C.: The subcutaneous route to insulindependent diabetes therapy. IEEE Engineering in Medicine and Biology 20, 54–64 (2001)
Gómez, E.J., Pérez, M.E.H., Vering, T.: The INCA System: A Further Step Towards a Telemedical Artificial Pancreas. IEEE Transactions on Information Technology In Biomedicine 12(4) (2008)
World Health Organization, Fact Sheet No. 138 (April 20, 2011) (Online), http://www.who.int/mediacentre/factsheets/fs138/en/
Carson, E.R., Cobelli, C. (eds.): Modelling Methodology for Physiology and Medicine. Academic Press, San Diego (2001)
Parker, R.S., Doyle III, F.J., Peppas, N.A.: The intravenous route to blood glucose control. IEEE Eng. Med. Biol. Mag. 20(1), 65–73 (2001)
Bellazzi, R., Nucci, G., Cobelli, C.: The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng. Med. Biol. Mag. 20(1), 54–64 (2001)
Hovorka, R.: Continuous glucose monitoring and closed-loop systems. Diabet. Med. 23, 1–12 (2005)
Bequette, B.W.: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 7(1), 28–47 (2005)
Owens, C., Zisser, H., Jovanovic, L., Srinivasan, B., Bonvin, D., Doyle III, J.: Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus. IEEE Trans. Biomed. Eng. 53(6), 996–1005 (2006)
Dudde, R., Vering, T., Piechotta, G., Hintsche, R.: Computer-aidedcontinuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin. IEEE Trans. Inf. Technol. Biomed. 10(2), 395–402 (2006)
Phee, H.K., Tung, W.L., Quek, C.: A personalised approach to insulin regulation using brain inspired neural semantic memory in biabetic glucose control. In: IEEE CEC (2007)
Hovorka, R.: The future of continuous glucose monitoring: closed-loop. Current Diabetes Reviews 4(3), 269–279 (2008)
Chee, E., Fernando, T., van Heerden, P.V.: Simulation study on automatic blood glucose control. In: 7th Australian and New Zealand Intelligent Information Systems Conference (2001)
Demuth, H., Beale, M.: Neural Network Toolbox for use with MATLAB, Mathworks
Renard, E., Costalat, G., Chevassus, H., Bringer, J.: Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 32(5 Pt 2), 497–502 (2006)
Chee, F., Savkin, A.V., Fernando, T.L., Nahavandi, S.: Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients. IEEE Transactions on Biomedical Engineering 52(10), 1625–1631 (2005)
Chen, J., Cao, K., Sun, Y., Xiao, Y., Su (Kevin), X.: Continuous Drug Infusion for Diabetes Therapy:A Closed-Loop Control System Design. EURASIP Journal onWireless Communications and Networking, Article ID 495185 (2008)
El Jabali, A.K.: Neural network modeling and control of type 1 diabetes melli- tus. Bioprocess Biosyst. Eng. 27, 75–79 (2005)
Matlab Simulink R2011a Documentation (Online), http://www.mathworks.com/help/toolbox/slcontrol/ug/br684zf.html
David C. Klonoff, The Artificial Pancreas: How Sweet Engineering Will Solve Bitter Problems, Journal of Diabetes Science and Technology, 2007, Volume 1, Issue 1.
Hung T. Nguyen, N.Ghevondian, and T. W. Jones , Real-time Detection of Nocturnal Hypoglycemic Episodes using a Novel Non-invasive Hypoglycemia Monitor , 31st Annual International Conference of the IEEE EMBS ,2009.
Heller, S.R., Macdonald, I.A.: Physiological disturbances in hypoglycemia: effect on subjective awareness. Clin. Sci. 81, 1–9 (1991)
Gale, E.A.M., Bennett, T., MacDonald, I.A., Holst, J.J., Matthews, J.A.: The physiological effects of insulin-induced hypoglycemia in man: responses at differing levels of blood glucose. Clin. Sciences 65, 263–271 (1983)
Marques, J.L., et al.: Altered ventricular repolarisation during hypoglycaemic in patient with diabetes. Diabetic Med. 8, 648–654 (1997)
Koivikko, M.L., Salmela, P.I., et al.: Effects of Sustained Insulin-Induced Hypoglycemia on Cardiovascular Autonomic Regulation in Type 1 Diabetes. Diabetes 54, 745–750 (2005)
Castle, J.R., Engle, J.M., Youseff, J.E., et al.: Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes. Diabetes Care 33(6), 1282–1287 (2010)
Heger, G., Howorka, K., Thoma, H., Tribl, G., Zeitlhofer, J.: Monitoring setup for selection of parameters for detection of hypoglycemia in diabetic patients. Medical & Biological Engineering & Computing (1996)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Qaisar, S.B., Khan, S.H., Imtiaz, S. (2012). Neural Network and Physiological Parameters Based Control of Artificial Pancreas for Improved Patient Safety. In: Murgante, B., et al. Computational Science and Its Applications – ICCSA 2012. ICCSA 2012. Lecture Notes in Computer Science, vol 7335. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31137-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-31137-6_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31136-9
Online ISBN: 978-3-642-31137-6
eBook Packages: Computer ScienceComputer Science (R0)